Lantheus Holdings, Inc. (LNTH) Given Consensus Rating of “Buy” by Analysts
Lantheus Holdings, Inc. (NASDAQ:LNTH) has been given a consensus recommendation of “Buy” by the six research firms that are covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $18.75.
A number of brokerages have recently issued reports on LNTH. Jefferies Group LLC reaffirmed a “buy” rating and issued a $22.00 price objective (up previously from $18.00) on shares of Lantheus Holdings in a research note on Wednesday, August 2nd. Zacks Investment Research cut shares of Lantheus Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, September 20th. Cantor Fitzgerald began coverage on shares of Lantheus Holdings in a research note on Monday, July 17th. They issued an “overweight” rating and a $22.00 price objective for the company. Credit Suisse Group upped their price objective on shares of Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, August 2nd. Finally, BidaskClub cut shares of Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 17th.
In other Lantheus Holdings news, major shareholder Avista Capital Partners Gp, Ll sold 87,939 shares of the stock in a transaction on Monday, August 14th. The shares were sold at an average price of $17.40, for a total transaction of $1,530,138.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Mary Anne Heino sold 10,000 shares of the stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $18.05, for a total transaction of $180,500.00. Following the sale, the chief executive officer now directly owns 592,468 shares of the company’s stock, valued at approximately $10,694,047.40. The disclosure for this sale can be found here. Insiders have sold a total of 906,344 shares of company stock valued at $15,499,626 in the last three months. 2.30% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. Systematic Financial Management LP purchased a new stake in Lantheus Holdings during the 1st quarter valued at $1,314,000. Royce & Associates LP purchased a new stake in Lantheus Holdings during the 2nd quarter valued at $4,896,000. Bank of New York Mellon Corp boosted its position in Lantheus Holdings by 6.3% during the 1st quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock valued at $856,000 after buying an additional 4,084 shares during the period. FNY Partners Fund LP purchased a new stake in Lantheus Holdings during the 1st quarter valued at $174,000. Finally, California Public Employees Retirement System boosted its position in Lantheus Holdings by 29.2% during the 1st quarter. California Public Employees Retirement System now owns 77,800 shares of the medical equipment provider’s stock valued at $973,000 after buying an additional 17,600 shares during the period. 84.35% of the stock is owned by institutional investors and hedge funds.
Lantheus Holdings (NASDAQ:LNTH) opened at 18.00 on Friday. The stock’s 50 day moving average is $17.46 and its 200-day moving average is $17.46. The firm has a market cap of $672.30 million, a price-to-earnings ratio of 24.59 and a beta of 0.91. Lantheus Holdings has a one year low of $7.61 and a one year high of $18.33.
Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings data on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.24 by $0.18. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The company had revenue of $88.83 million during the quarter, compared to analysts’ expectations of $80.56 million. During the same quarter in the prior year, the company earned $0.24 EPS. The firm’s revenue was up 13.9% on a year-over-year basis. On average, equities research analysts expect that Lantheus Holdings will post $1.12 earnings per share for the current fiscal year.
About Lantheus Holdings
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.